Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease

American Journal of Gastroenterology

Volumn 93, Issue 8, 1998, Pages 1306-1310

  Sendid, Boualem ^b   Quinton, Jean François ^b   Charrier, Gwénaële ^b   Goulet, Olivier ^b   Cortot, Antoine ^b   Grandbastien, Bruno ^b   Poulain, Daniel ^b   Colombel, Jean Frédéric ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; MANNAN;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FAMILY STUDY; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; PEDIGREE; PREVALENCE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHILD; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC MARKERS; HUMANS; MALE; MANNANS; MIDDLE AGED; PEDIGREE; PREVALENCE; SACCHAROMYCES CEREVISIAE;

EID: 0004200689     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00415.x     Document Type: Article

References (23)

1. 1. Yang H, Rotter JL. Genetics of inflammatory bowel disease. In: Targan SR, Shanahan F, eds. Inflammatory bowel disease: From bench to bedside. Baltimore: Williams & Wilkins, 1994:32-64.
2. 2. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379:821-3.
3. 3. Ohmen JD, Yang HY, Yamamoto KK, et al. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet 1996;5:1679-83.
4. 4. Satsangi J, Parkes M, Louis E, et al. Two stage genome-wide search in inflammatory bowel disease provide evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genet 1996;14:199-202.
5. 5. Korsmeyer SJ, Wiliams RC Jr, Wilson ID, et al. Lymphocytotoxic antibody in inflammatory bowel disease - a family study. N Engl J Med 1975;293:1117-20.
6. 6. Hollander D, Vadheim CM, Brettholtz E, et al. Increased intestinal permeability in Crohn's patients and their relatives: An etiological factor? Ann Intern Med 1986;105:883-95.
7. 7. Elmgreen J, Both H, Binder V. Familial occurrence of complement dysfunction in Crohn's disease: Correlation with intestinal symptoms and hypercatabolism of complement. Gut 1985;26:151-7.
8. 8. Van de Merwe JP, Schroder AM, Wensinck F, et al. The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives. Scand J Gastroenterol 1988;23:1125-31.
9. 9. Tysk C, Riedesel H, Lindberg E, et al. Colonic glycoprotein in monozygotic twins with inflammatory bowel disease. Gastroenterology 1991;100:419-23.
10. 10. Helgeland L, Tysk C, Järnerot G, et al. IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease. Gut 1992;33:1358-64.
11. 11. Shanahan F, Duerr RH, Rotter JI, et al. Neutrophil autoantibodies in ulcerative colitis: Familial aggregation and genetic heterogeneity. Gastroenterology 1992;103:456-61.
12. 12. Fiocchi C, Roche JK, Michener WM. High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. Ann Intern Med 1989;110:786-94.
13. 13. Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease. Br Med J 1988;297: 1105-6.
14. 14. Barnes RMR, Allan S, Taylor-Robinson CH, et al. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease. Is IgA antibody a marker for Crohn's disease? Int Arch Allergy Appl Immunol 1990;92:9-15.
15. 15. Giaffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992;33:1071-5.
16. 16. Sendid B, Colombel JF, Jacquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diag Lab Immunol 1996;3:219-26.
17. 17. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan combined with antineutrophil antibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 1998;42:788-91.
18. 18. Colombel JF, Grandbastien B, Gower-Rousseau C, et al. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 1996;111:604-7.
19. 19. Colton T. Statistics in medicine. Boston: Little Brown, 1974.
20. 20. Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994;35: 1433-8.
21. 21. Lindberg E, Magnusson KE, Tysk C, et al. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut 1992;33:909-13.
22. 22. May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 1993;104:1627-32.
23. 23. Peelers M, Geypens B, Claus D, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997;113:802-7.